Literature DB >> 6465992

Congenital cardiac anomalies associated with the DiGeorge syndrome: a neonatal experience.

L M Marmon, R K Balsara, R Chen, J M Dunn.   

Abstract

The DiGeorge syndrome is a rare congenital abnormality of absent of hypoplastic thymus and parathyroid glands. Thirty neonates who had cardiac lesions and the DiGeorge syndrome are reviewed. The early mortality for 10 neonates undergoing palliative procedures was 80%. Seventy-five percent of the deaths were secondary to sepsis. Twenty neonates did not undergo palliative procedures. In this group, early mortality was 60% and late mortality was 65%. Sixty percent of the deaths in this group were associated with sepsis, with cardiac failure responsible for the remaining deaths. Survival in both groups has improved with appropriate treatment of the immunological and metabolic consequences of the DiGeorge syndrome.

Entities:  

Mesh:

Year:  1984        PMID: 6465992     DOI: 10.1016/s0003-4975(10)62223-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Recurrence risk figures for isolated tetralogy of Fallot after screening for 22q11 microdeletion.

Authors:  M C Digilio; B Marino; A Giannotti; A Toscano; B Dallapiccola
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

Review 2.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

3.  Spectrum of Di George syndrome in patients with truncus arteriosus: expanded Di George syndrome.

Authors:  D J Radford; L Perkins; R Lachman; Y H Thong
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

4.  Chromosomal Abnormalities Affect the Surgical Outcome in Infants with Hypoplastic Left Heart Syndrome: A Large Cohort Analysis.

Authors:  Dala Zakaria; Xinyu Tang; Rupal Bhakta; Nahed O ElHassan; Parthak Prodhan
Journal:  Pediatr Cardiol       Date:  2017-09-18       Impact factor: 1.655

Review 5.  The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome.

Authors:  W Müller; H H Peter; M Wilken; H Jüppner; H C Kallfelz; H P Krohn; K Miller; C H Rieger
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

Review 6.  22q11.2 Deletion Syndrome: Impact of Genetics in the Treatment of Conotruncal Heart Defects.

Authors:  Carolina Putotto; Flaminia Pugnaloni; Marta Unolt; Stella Maiolo; Matteo Trezzi; Maria Cristina Digilio; Annapaola Cirillo; Giuseppe Limongelli; Bruno Marino; Giulio Calcagni; Paolo Versacci
Journal:  Children (Basel)       Date:  2022-05-25

7.  22q11 deletions in isolated and syndromic patients with tetralogy of Fallot.

Authors:  F Amati; A Mari; M C Digilio; R Mingarelli; B Marino; A Giannotti; G Novelli; B Dallapiccola
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

8.  22q11.2 Deletion syndrome is associated with increased perioperative events and more complicated postoperative course in infants undergoing infant operative correction of truncus arteriosus communis or interrupted aortic arch.

Authors:  Michael L O'Byrne; Wei Yang; Laura Mercer-Rosa; Aimee S Parnell; Matthew E Oster; Yosef Levenbrown; Ronn E Tanel; Elizabeth Goldmuntz
Journal:  J Thorac Cardiovasc Surg       Date:  2014-02-10       Impact factor: 5.209

9.  Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome).

Authors:  Mc Digilio; B Marino; R Capolino; B Dallapiccola
Journal:  Images Paediatr Cardiol       Date:  2005-04

10.  A subpopulation of smooth muscle cells, derived from melanocyte-competent precursors, prevents patent ductus arteriosus.

Authors:  Ichiro Yajima; Sophie Colombo; Isabel Puig; Delphine Champeval; Mayuko Kumasaka; Elodie Belloir; Jacky Bonaventure; Manuel Mark; Hiroaki Yamamoto; Mark M Taketo; Philippe Choquet; Heather C Etchevers; Friedrich Beermann; Véronique Delmas; Laurent Monassier; Lionel Larue
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.